AZTR · Azitra, Inc.
$0.14
0.00 (-0.50%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events create substantial doubt about the ability of the Company to continue as a going concern for twelve months from the date that the financial statements are available to be issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$8.44M
Shares
60.60M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$10.96M
-22.2%
FY2025
Operating Margin
-146468.53%
-145382.4pp
FY2024
Diluted EPS
-$2.25
+85.7%
FY2025
Operating Cash Flow
-$11.22M
-10.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| — | $0 | $7500 | $686K | $284K | |
| $5.1M | $4.84M | $4.72M | $3.64M | $6.1M | |
| $7.25M | $6.13M | $6.27M | $4.49M | $3.64M | |
| $16.83K | $13.71K | $11.16K | $7643 | $5234 | |
| — | $138.07K | $131.19K | $129.65K | $125.89K | |
| $12.35M | $10.97M | $10.99M | $8.14M | $9.74M | |
| -$12.35M | -$10.97M | -$10.99M | -$7.45M | -$9.45M | |
| — | — | -146468.53% | -1086.09% | -3328.73% | |
| — | -$10.83M | -$10.85M | -$7.32M | -$9.33M | |
| $10.6K | $7587 | $12.16K | $167.73K | $251.89K | |
| $83.55K | $19.61K | $2.03M | -$3.82M | -$1.23M | |
| -$12.26M | -$10.95M | -$8.96M | -$11.27M | -$10.68M | |
| $8319 | $8319 | $9031 | $17.31K | — | |
| -$12.27M | -$10.96M | -$8.97M | -$11.28M | -$10.68M | |
| — | — | -119566.56% | -1644.87% | -3760.69% | |
| — | — | -$8.97M | -$12.64M | -$13.45M | |
| USD/shares | — | -$2.25 | -$15.70 | -$366.53 | -$2,548.00 |
| USD/shares | — | -$2.25 | -$15.70 | -$366.53 | -$2,548.00 |
| shares | — | 4.87M | 571.16K | 34.48K | 5276.995 |
| shares | — | 4.87M | 571.16K | 34.48K | 5276.995 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.60×
EV/EBIT
—
P/E (TTM)
—
Peer median 2.97×
Peer medians compare against the 191 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1701478
CUSIP
05479L302
13F (30d)
16 filings
15 filers
Visit website
Investor relations